3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
24-Week Recurrence Rate of Gout Following Firsekibart TreatmentGout FlareNot yet recruitingNot applicable2026-06-04NCT07625514
Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled TrialGout FlaresNot yet recruitingNot applicable2026-06-01NCT07616531
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort StudyInfections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorderRecruitingNot stated2025-08-07NCT06114784